News Articles

Cerba Healthcare Enters Agreement to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Clinical Trials ... ISSY LES MOULINEAUX, France & ROTTERDAM, The Netherlands -Thursday 16 December 2021  

(BUSINESS WIRE)-- Cerba HealthCare, a leading global player in medical diagnosis, today announced it has reached agreement to acquire Viroclinics-DDL, a fast-growing global virology and immunology contract research organization (CRO) from Summit Partners. This press release features...

Covid - 19: Laboratoire Cerba Detects First Case of Omicron Variant in Mainland France -Friday 3 December 2021  

(BUSINESS WIRE) -- Laboratoire Cerba, a global leader in specialized clinical pathology and member of the Cerba HealthCare Group, has detected a case of the Omicron variant from the sample of a patient arriving from Nigeria who was tested at Roissy Charles De Gaulle airport. The authorities -...

Major Advances in Diagnosing Cancers Associated With the Human Papillomavirus -Thursday 25 November 2021  

(BUSINESS WIRE)-- The Institut de Cancérologie de Lorraine [the Lorraine Institute of Oncology, or ICL] in collaboration with the Institut du Cancer Joliot Curie [the Joliot Curie Cancer Institute] in Dakar and the Cerba HealthCare Group has recently finalized research demonstrating that it is...

Working Towards Better Tuberculosis Screening in Developing Countries: EpiLAB Joins the Cerba HealthCare Group’s... -Friday 19 November 2021  

(BUSINESS WIRE) -- According to the World Health Organisation, tuberculosis has been the world’s leading cause of infectious mortality for more than 20 years. Every year, 10 million people contract tuberculosis, and of these, an estimated one third of new cases are undetected. These 3 million...